Lyell Immunopharma Inc.

0.48
-0.03 (-5.42%)
At close: Apr 03, 2025, 12:57 PM

Lyell Immunopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
61K 130K 84.68M 10.65M 7.76M 657K
n/a n/a 16.47M 14.54M 7.47M n/a
61K 130K 68.22M -3.88M 281K 657K
-3.31M -247.01M -183.12M -214.78M -211.94M -102.09M
24.07M 23.45M 7.05M 1.17M 5.94M 8.12M
-342.99M -234.63M -183.12M -250.22M -204.47M -129.38M
-342.99M -234.63M -4.75M -285.5M -198.53M -121.26M
52.04M 66.98M 117.31M 89.06M 46.88M 39.15M
171.6M 182.94M 159.19M 138.69M 182.24M 63.59M
135.17M -2.79M 1.89M -2.32M -9.43M -35.41M
358.82M 247.14M 276.5M 225.43M 219.69M 102.75M
n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a
358.82M 247.14M 276.5M 225.43M 219.69M 102.75M
n/a n/a -178.36M 35.28M -5.94M -8.12M
261.48M 250.98M 247.08M 242.74M 246.58M 246.58M
261.48M 250.98M 247.08M 242.74M 246.58M 246.58M
-1.31 -0.93 -0.02 -1.18 -0.81 -0.49
-1.31 -0.93 -0.02 -1.18 -0.81 -0.49
-3.31M -226.76M -166.65M -199.94M -207.64M -100.83M
n/a -247.01M -187.06M -214.78M -211.94M -102.09M
n/a 20.25M 16.47M 14.54M 7.47M 4.38M